China Pharma Holdings, Inc. (NYSE:CPHI) (“China Pharma”, the “Company” or “We”), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced the launch of N95 medical protective mask (“N95 mask”).
YMTC Ban Likely A Plus For Micron & Western Digital, While A Minus For AMD & NVIDIA, Analyst Says
Mizuho analyst Vijay Rakesh saw the potential for a Yangtze Memory Technologies Co ban and expanding restrictions from AI or GPUs…
